Trademark: 88339989
Word
DIAFERT
Status
Dead
Status Code
602
Status Date
Monday, August 17, 2020
Serial Number
88339989
Mark Type
4000
Filing Date
Thursday, March 14, 2019
Abandoned Date
Wednesday, August 5, 2020

Trademark Owner History

Classifications
5 Pharmaceutical preparations used in connection with anti-aging, namely, pharmaceutical preparations for use in the treatment of glabellar lines, facial wrinkles, facial asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma agents and decongestants; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing pharmaceutical preparations; pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; pharmaceutical preparations and medicines for the treatment of sensory organ disorders; pharmaceutical preparations and medicines for the treatment of central nervous system disorders; pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; pharmaceutical preparations and medicines for the treatment of circulatory system disorders; pharmaceutical preparations and medicines for the treatment of cardiovascular diseases and high blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations for supporting, encouraging and promoting bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; antivirals; antiprotozoans, namely, pharmaceutical preparations for treating infections caused by protozoa; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS (central nervous system) disorders, neurological disorders, neurodegenerative disorders and depression; neuroprotective agent, namely, pharmaceutical preparations to help prevent or reduce damage to the brain or spinal cord; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents, namely, pharmaceutical preparations for dilating blood vessels; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenating creams, rehydrating creams and lotions for the face and body, excluding iron preparations for pharmaceutical use and iron preparations as food supplements

Trademark Events
Aug 17, 2020
Abandonment Notice E-Mailed - Failure To Respond
Aug 17, 2020
Abandonment - Failure To Respond Or Late Response
Feb 4, 2020
Notification Of Final Refusal Emailed
Feb 4, 2020
Final Refusal E-Mailed
Feb 4, 2020
Final Refusal Written
Jan 13, 2020
Teas/Email Correspondence Entered
Jan 13, 2020
Correspondence Received In Law Office
Jan 9, 2020
Assigned To Lie
Dec 17, 2019
Teas Response To Office Action Received
Dec 13, 2019
Notification Of Non-Final Action E-Mailed
Dec 13, 2019
Non-Final Action E-Mailed
Dec 13, 2019
Non-Final Action Written
Nov 21, 2019
Teas/Email Correspondence Entered
Nov 21, 2019
Correspondence Received In Law Office
Nov 21, 2019
Teas Response To Office Action Received
May 29, 2019
Notification Of Non-Final Action E-Mailed
May 29, 2019
Non-Final Action E-Mailed
May 29, 2019
Non-Final Action Written
May 23, 2019
Assigned To Examiner
Apr 2, 2019
New Application Office Supplied Data Entered In Tram
Mar 18, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24